ACCESS Forum published Part 1 of Issue 5 covering Foundational Resets, including re-building the floor-and-ceiling corridor, retiring Germany and Japan as stable reference points, and designing Phase II/III protocols with multi-market comparator logic before global protocol lock.
Public source
Publisher name
Public post
Global teams have never priced to one number. Every launch has run on an affiliate floor-and-ceiling range, with HQ approval required beyond it. What is ending is the an…
Company
ACCESS Forum
The Davos of the ACCESS World - Your Home for Patient & Market Access, Pricing, and Reimbursement
- Industry
- Industry Associations
- Location
- Tampa, US
- Company size
- 11–50 employees
About ACCESS Forum
ACCESS FORUM is the first international community of Market and Patient Access experts, professionals, and stakeholders to focus on seminal question: How can we ensure optimal access to treatments and technologies across healthcare, culminating with the right patient, right treatment, right time, right setting, at a fair price? Our VISION is this: We aspire to be the global voice and Center of Excellence for promoting market and patient access to innovative healthcare products, technologies, and services. Our MISSION is to convene, connect, and engage members and other stakeholders across the Market & Patient Access ecosystem to: •Accelerate access to healthcare innovation and promote efficient and equitable healthcare delivery •Develop, collect, and disseminate best practices in Market & Patient Access •Shape the discussions and policies that are driving Market and Patient Access globally •Enhance the competencies and skill sets of professionals in the Access arena •Drive innovation in access, pricing, and reimbursement—and the evidence requisite in those disciplines
See moreLatest activity
Latest activity from ACCESS Forum
4 signals
Presence & Recognition
ACCESS Forum hosted three sessions at the ACCESS EU 26 conference in Lisbon, including WS 2 on HTA or Cost Containment, WS 3 on Gene Therapy Commercialization, and WS 15 on the Value of Precision Medicine.
Presence & Recognition
ACCESS Forum announced the first sessions for ACCESS US '27 Miami, featuring policy and global access, digital health and AI, evidence, value and pricing, and a pre-Forum workshop.
Presence & Recognition
ACCESS Forum hosted seven sessions at the ACCESS EU 26 conference in Lisbon, covering market access, global policy shifts, and global biopharmaceutical ecosystems.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Access Infinity
Access Infinity published a whitepaper exploring the challenge of GLP-1s moving beyond obesity, value stories, pricing architecture, and indication sequencing.
Research & Knowledge
RapidAccess.ai
RapidAccess.ai published evaluations from INESSS, six new CDA-AMC files opened for input, and a pCPA negotiation that closed without an agreement.
Research & Knowledge
Partners4Access
Partners4Access developed PICO+ to identify and consolidate clinical evidence for PICOs in disease areas with limited HTA precedent and clinical guidelines.
Research & Knowledge
MA360i
MA360i tracks how evidence translates into coverage decisions for ctDNA-MRD in solid-tumor drug development.
Research & Knowledge
Kintiga